scPharmaceuticals Inc. (NASDAQ:SCPH) Q1 2025 Earnings Call Transcript
Operator: Good afternoon and welcome to scPharmaceuticals First Quarter 2025 Earnings Conference Call. At this time all participants are in a listen-only mode.
Scpharmaceuticals Inc. (SCPH)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | AIGH Investment Partners Orin Hirschman | 3,867,523 | $14,735,262 | -6% | 6.63% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.00 | 21,658 | $86,632.00 | 252,858 | 2024-08-13 | Filing | |
| $4.00 | 478,342 | $1,913,368.00 | 5,806,670 | 2024-08-13 | Filing | |
| $5.25 | 762,380 | $4,002,495.00 | 5,328,328 | 2022-11-25 | Filing | |
| $3.91 | 5,000 | $19,569.00 | 5,000 | 2021-12-03 | Filing | |
| $3.96 | 10,000 | $39,553.00 | 46,962 | 2021-12-03 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.09 | 87,036 | $355,977.24 | 410,268 | 2022-10-10 | Filing | |
| $4.09 | 19,017 | $77,779.53 | 92,983 | 2022-10-10 | Filing | |
| $4.09 | 456,413 | $1,866,729.17 | 2,231,601 | 2022-10-10 | Filing | |
| $5.02 | 5,808 | $29,156.16 | 497,304 | 2022-10-06 | Filing | |
| $5.02 | 1,269 | $6,370.38 | 112,000 | 2022-10-06 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 3,541,170 | $13,491,858 | 0.06% | |
| 2. | 749,484 | $2,855,760 | 0% | |
| 3. | 81,458 | $310,356 | 0% | |
| 4. | 37,500 | $142,875 | 0.01% | |
| 5. | 28,670 | $109,233 | 0% |
News See All
scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to scPharmaceuticals Fourth Quarter and Full Year 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, and welcome to scPharmaceuticals' Third Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q2 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the scPharmaceuticals Second Quarter 2024 Earnings Conference Call. At this time all participants are in a listen-only mode.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the scPharmaceuticals First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcript
scPharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.35, expectations were $-0.48.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by. This is the conference operator. Welcome to the scPharmaceuticals Third Quarter 2023 Earnings Conference Call.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q2 2023 Earnings Call Transcript
Operator: Good day and welcome to the scPharmaceuticals Second Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q1 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the scPharmaceuticals First Quarter 2023 Earnings Conference Call. At this time, all participants are in listen-only mode.
scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2022 Earnings Call Transcript
PJ Kelleher: Thank you, operator. Before turning the call over to management, I would like to make the following remarks concerning forward-looking statements.
Billionaire Hedge Funds
